BS degree in a biological science or related discipline
Quality Assurance experience in a GCP-regulated environment
Experience in clinical audit and inspection management
Excellent interpersonal and negotiation skills
Strong analytical skills and ability to work independently with minimal supervision
Responsibilities
Conduct external audits of clinical investigator sites and CROs
Develop and issue detailed Audit Reports with risk categorization
Identify non-compliance trends and communicate findings to management
Support initiatives to enhance SOPs for audits
Maintain knowledge of global GCP regulations and industry trends
Benefits
Opportunities for professional development in a dynamic environment
Collaborative team culture with emphasis on continuous improvement
Exposure to global audit activities and regulatory frameworks
Flexibility to work in diverse clinical settings
Potential for significant impact on clinical data integrity and trial success.
Full Job Description
The Opportunity:
This role serves as a GCP Auditor within our Research & Development Quality audit program, responsible for executing the global audit plan to ensure the accuracy of clinical trial data and compliance with legal and corporate standards.
By conducting audits of our clinical investigator sites, external vendors, and internal trial management processes, you identify the findings and non-compliance trends that could impact the integrity of our clinical research. Seeking an experienced auditor who can navigate complex clinical environments and work collaboratively with stakeholders to develop corrective actions that ensure long-term systemic stability.
The Role:
Audit Execution: Conduct assigned external audits of clinical investigator sites, Contract Research Organizations (CROs), E-System providers, and Institutional Review Boards (IRBs/ECs).
Reporting & Risk Categorization: Develop and issue comprehensive Audit Reports, categorizing findings by risk level and providing recommendations for corrective and preventive actions (CAPA) related to trial conduct and data integrity.
Trend Analysis: Identify non-compliance trends and systematic risks within the Clinical (GCP) discipline, communicating these findings to line management and clinical functional leads to ensure trial robustness.
Continuous Improvement: Support initiatives to improve standard operating procedures (SOPs) for audit conduct and partner with stakeholders to develop risk-based, compliant solutions for clinical trial management and monitoring.
Regulatory Knowledge: Maintain up-to-date knowledge of global GCP regulations (ICH E6) and industry trends, identifying new requirements to ensure a high level of quality is maintained across all clinical development programs.
Skills and Experience:
Academic Background: BS degree in a relevant biological science, science, or related discipline
Professional Experience: 3+ years of Quality Assurance experience within a GCP-regulated environment, demonstrating a strong understanding of clinical trial phases, monitoring, and regulatory frameworks.
Audit Expertise: Experience in clinical audit and inspection management, with a clear understanding of the requirements for quality assurance in the clinical research discipline.
Communication Skills: Excellent interpersonal and negotiation skills, with the ability to work effectively with multinational clinical teams, investigators, and external CROs.
Working Knowledge of:
ICH E6 (R3) Guideline
21 CFR Part 11 – Electronic Records; Electronic Signatures
21 CFR Part 50 – Protection of Human Subjects (Informed Consent)
21 CFR Part 312 – Investigational New Drug Application
21 CFR Part 812 – Investigational Device Exemptions
Clinical Trials Regulation (CTR) (EU) No 536/2014
Directive 2001/20/EC (Clinical Trial Directive)
Directive 2005/28/EC (GCP Directive)
Directive 2001/83/EC (Annex I)
Organizational Agility: Strong analytical and problem-solving skills, with the ability to work with limited supervision and manage a schedule that includes up to 50% travel.
About CSL Limited
CSL Limited is a global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines to protect public health. They have a focus on rare and serious diseases, and their products are used in more than 70 countries. CSL Limited was founded in 1916 in Australia, and has since grown to become one of the largest biotech companies in the world. They have a strong commitment to research and development, and invest heavily in new technologies and therapies. CSL Limited is listed on the Australian Securities Exchange and the NASDAQ, and has a market capitalization of over $100 billion.